Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)

Common Size Income Statement

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Cost of goods sold  30.6%30.8%29.2%39.4%51.7%38.1%34.5%16.4%
Gross profit  69.4%69.2%70.8%60.6%48.3%61.9%65.5%83.6%
Selling, general and administrative  108.1%168.9%13.8%85.4%22.9%57.8%36.6%45.7%
Research and development       1.2%1.5%3.0%
General and administrative          
EBITDA  -38.4%-99.1%-44.2%-24.5%-39.8%3.3%26.2%32.7%
Depreciation  0.3%0.5%0.2%0.3%0.8%0.5%0.2%0.2%
EBITA  -38.7%-99.6%-44.4%-24.8%-40.6%2.7%26.1%32.5%
Amortization of intangibles       4.7%3.6%3.5%
EBIT  -38.7%-99.6%-44.4%-24.8%-40.6%-1.6%23.8%29.0%
Pre-tax income  -52.6%-120.1%-80.3%-40.3%-54.7%-2.9%21.3%37.0%
Income taxes  0.3%0.3%4.0%-11.3%-24.5%-0.6%7.6%4.5%
Net income  0.0%0.0%0.0%-29.0%-33.7%-2.3%13.8%28.0%

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy